This site is currently implementing core features and is not ready for patient use yet.
This site is currently implementing core features and is not ready for patient use yet.
For informational purposes only — not medical advice
How serious?
Risk of death
No
Vaccine available?
Time to symptoms
Countries affected
Active outbreaks
Risk increases with freshwater activities (swimming, kayaking, rafting) in tropical regions, especially after heavy rainfall/flooding. Avoid wading through floodwater. Cover cuts and abrasions. Seek medical care for fever with muscle pain after water exposure.
Bacterial zoonosis acquired through contaminated water or soil. A leading cause of illness after floods and in adventure travelers. Treatable with antibiotics if caught early.
Symptoms | Frequency | Severity | Onset |
|---|---|---|---|
| Conjunctivitis | 40% | Mild | Early |
| Chills | 70% | Mild | Early |
| Fever | 97% | Moderate | Early |
| Headache | 98% | Moderate | Early |
| High fever | 75% | Moderate | Early |
| Myalgia | 90% | Moderate | Early |
| Back pain | 50% | Mild | Early |
| Loss of appetite | 65% | Mild | Early |
| Malaise | 65% | Mild | Early |
| Nausea | 60% | Mild | Early |
| Retro-orbital pain | 35% | Mild | Early |
| Vomiting | 50% | Mild | Early |
| Rash | 10% | Mild | Early |
| Jaundice | 10% | Severe | Peak |
| Oliguria | 15% | Severe | Peak |
| Dark urine | 12% | Moderate | Peak |
| Hemoptysis | 3% | Critical | Peak |
| Hemorrhage | 5% | Severe | Peak |
| Hepatomegaly | 25% | Mild | Peak |
| Hypotension | 8% | Severe | Peak |
| Shortness of breath | 8% | Severe | Peak |
| Petechiae | 8% | Mild | Peak |
| Splenomegaly | 15% | Mild | Peak |
| Abdominal pain | 40% | Mild | Any phase |
| Cough | 25% | Mild | Any phase |
| Diarrhea | 30% | Mild | Any phase |
| Tachycardia | 30% | Mild | Any phase |
Leptospirosis is an acute bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira, with over 300 serovars identified across more than 20 pathogenic species. It is considered the most widespread zoonotic disease in the world, affecting both tropical and temperate regions.
The bacteria are maintained in the renal tubules of chronically infected reservoir animals, particularly rats and other rodents, but also dogs, cattle, pigs, and horses. Leptospira organisms are shed in animal urine and can survive for weeks to months in warm, moist environments. Humans acquire infection through contact of mucous membranes or abraded skin with contaminated water, soil, or animal urine.
Leptospirosis has a remarkably broad clinical spectrum. The majority of infections are subclinical or cause a mild, self-limiting febrile illness. However, 5-15% of symptomatic patients develop severe disease, known as Weil disease (icteric leptospirosis), characterized by jaundice, renal failure, and hemorrhage, with a case fatality rate of 5-15%. Severe pulmonary hemorrhage syndrome (SPHS), an increasingly recognized complication, has a CFR exceeding 50%.
The global burden is estimated at approximately 1 million cases and 58,900 deaths annually (GBD 2015), making leptospirosis one of the leading causes of death among zoonotic diseases. The disease disproportionately affects tropical low-income countries and is increasingly recognized as a significant cause of acute febrile illness in travelers returning from endemic areas.
Clinical Overview
Leptospirosis is a neglected tropical disease with global distribution, significant morbidity and mortality, and growing relevance for travelers and urban populations in tropical settings.
Key Clinical Facts:
Causative agent: Pathogenic Leptospira species (>300 serovars; L. interrogans most common)
Transmission: Contact with water, soil, or mud contaminated with infected animal urine; direct animal contact; occupational and recreational exposure
Reservoir: Rats (primary), dogs, cattle, pigs, horses, wildlife
Incubation period: 2-30 days (typically 7-12 days)
Clinical spectrum: Subclinical (majority) → mild anicteric leptospirosis → severe Weil disease → SPHS
Case fatality rate: <5% overall; 5-15% for Weil disease; >50% for severe pulmonary hemorrhage syndrome
Treatment: Doxycycline (mild), IV penicillin or ceftriaxone (severe)
Global burden: ~1 million cases/year, ~58,900 deaths/year
Characteristic Biphasic Course: Leptospirosis classically follows a biphasic pattern:
Risk Groups:
Agricultural workers (rice paddies, sugarcane fields, livestock)
Sewage and sanitation workers
Military personnel deployed to tropical environments
Adventure travelers (white-water rafting, caving, jungle trekking)
Urban slum populations in tropical cities during flooding
Competitors in freshwater sports events (triathlon, eco-challenge races)
Emergency Warning Signs
Leptospirosis can progress rapidly to life-threatening Weil disease or severe pulmonary hemorrhage syndrome. Seek immediate emergency care if any of the following develop during or after a febrile illness with potential leptospirosis exposure:
Pulmonary Emergency (Highest Urgency):
Hemoptysis (coughing up blood) — may indicate severe pulmonary hemorrhage syndrome (CFR >50%)
Acute onset dyspnea with bilateral infiltrates
Rapidly progressive respiratory failure
Any cough with bloodstained sputum in a patient with suspected leptospirosis
Hepatorenal Emergency:
Jaundice (yellow skin and eyes) — indicates hepatic involvement and Weil disease
Decreased or absent urine output (oliguria/anuria) — renal failure
Dark (cola-colored) urine — may indicate renal involvement or rhabdomyolysis
Severe abdominal pain with hepatomegaly and tenderness
Peripheral edema and signs of fluid overload
Hemorrhagic Signs:
Bleeding from gums, nose, or injection sites
Petechiae, purpura, or ecchymoses
Blood in stool (melena, hematochezia) or vomit (hematemesis)
Cardiovascular Signs:
Chest pain, palpitations, or irregular heartbeat (myocarditis, arrhythmia)
Hypotension despite fluid intake
Signs of circulatory shock (cold extremities, rapid pulse, altered consciousness)
Neurological Signs:
Severe headache with neck stiffness (meningitis)
Confusion, altered mental status
Seizures
Clinical Context: These signs are particularly concerning if the patient has recently:
Been exposed to floodwaters, freshwater bodies, or contaminated soil in tropical areas
Participated in water sports, adventure activities, or agricultural work
Had contact with animals (especially rodents) or their urine
Most common signs and symptoms
Symptom Presentation
Leptospirosis presents with a broad clinical spectrum, from asymptomatic infection to fatal multi-organ failure. The classic presentation is a biphasic illness, though in severe cases the phases may merge.
Anicteric Leptospirosis (85-90% of symptomatic cases):
Phase 1 — Leptospiremic/Acute Phase (Days 1-7):
Abrupt onset of high fever (38-40°C), often with rigors
Severe headache — often frontal, retro-orbital, intense and unremitting
Myalgia — characteristically severe in the calves and lumbar region (highly suggestive of leptospirosis)
Conjunctival suffusion (bilateral conjunctival redness without exudate) — a distinctive early finding, present in 30-40% of cases
Nausea, vomiting, diarrhea, and abdominal pain
Non-productive cough in ~25% of patients
Hepatosplenomegaly in some cases
Transient maculopapular rash (rare)
Phase 2 — Immune Phase (Days 7-14):
After brief defervescence (1-3 days), fever recurs
Aseptic meningitis in up to 25% (headache, photophobia, neck stiffness; CSF lymphocytosis)
Uveitis (may be delayed weeks to months post-infection)
Rash
Most patients recover during this phase over 1-2 weeks
Severe Leptospirosis / Weil Disease (5-15% of symptomatic cases):
Jaundice: Deep icterus from hepatocellular dysfunction and cholestasis (bilirubin often >15 mg/dL)
Acute kidney injury: Oliguric or non-oliguric renal failure, characteristic hypokalemic nephropathy
Hemorrhage: Pulmonary hemorrhage, epistaxis, GI bleeding, petechiae, ecchymoses
Thrombocytopenia
Cardiovascular: Myocarditis, arrhythmias, hemodynamic instability
Phases tend to merge in severe disease without a clear biphasic pattern
Severe Pulmonary Hemorrhage Syndrome (SPHS):
Diffuse alveolar hemorrhage with hemoptysis, dyspnea, and respiratory failure
Can occur with or without jaundice/renal failure
Chest X-ray shows bilateral diffuse alveolar infiltrates
CFR >50%, often fatal within 72 hours of respiratory symptom onset
Knowing the symptoms is the first step to a quick response.
Disease Course and Progression
Leptospirosis classically follows a biphasic course, though this pattern is most apparent in mild-moderate disease. In severe cases, the phases may overlap or merge.
Exposure (Day 0):
Leptospira organisms penetrate intact mucous membranes (conjunctivae, oral, nasal) or abraded skin
Common exposure: wading in floodwaters, swimming in contaminated freshwater, contact with animal urine or contaminated soil
The organism enters the bloodstream rapidly, within minutes to hours
Incubation Period (Days 2-30, typically 7-12):
Spirochetes disseminate hematogenously to multiple organs (liver, kidneys, lungs, meninges, muscles)
Replication occurs in target organs and bloodstream
Patient is asymptomatic
Phase 1 — Leptospiremic/Septicemic Phase (Days 3-7 of illness):
Abrupt onset of high fever, chills, severe headache
Intense myalgia (calves, lumbar area — pathognomonic)
Conjunctival suffusion (30-40%) — a key clinical clue
Nausea, vomiting, abdominal pain
Leptospira present in blood and CSF; blood cultures positive
Resolves with brief defervescence (1-3 days)
Phase 2 — Immune Phase (Days 7-14 and beyond):
Coincides with development of IgM antibodies
Fever may recur (lower grade)
Aseptic meningitis (up to 25% of cases)
Organisms cleared from blood but may persist in kidneys, eyes, and brain
Uveitis may develop (sometimes weeks to months later)
Most patients recover fully during this phase
Severe Disease Progression (Weil Disease):
In 5-15% of symptomatic patients, disease progresses rapidly without a clear biphasic pattern
Days 4-7: Progressive jaundice, oliguric renal failure, hemorrhagic manifestations
Days 7-14: Peak organ dysfunction; ICU care required. Renal failure, hepatorenal syndrome, DIC.
If SPHS develops: Acute respiratory deterioration with diffuse alveolar hemorrhage, typically days 4-10 of illness. Can be fulminant.
Recovery:
Mild disease: 1-3 weeks to full recovery
Weil disease: 3-6 weeks of convalescence; renal function typically recovers
Urine shedding of Leptospira may continue for weeks to months
How this disease is identified
Diagnosis
Leptospirosis diagnosis is challenging because early symptoms mimic many other febrile illnesses. A high index of clinical suspicion based on epidemiological exposure is essential. Empiric treatment should not be delayed pending laboratory confirmation.
Clinical Clues: The combination of acute fever + severe myalgia (especially calves) + conjunctival suffusion + history of water/animal exposure is highly suggestive. Jaundice with acute kidney injury and hemorrhage (Weil disease) in a person with appropriate exposure should prompt immediate treatment.
Laboratory Diagnostic Methods:
Microscopic Agglutination Test (MAT) — Gold Standard:
IgM ELISA:
PCR (Polymerase Chain Reaction):
Culture:
Dark-Field Microscopy:
Supporting Laboratory Findings:
Mild to moderate leukocytosis (often with left shift)
Thrombocytopenia (common in severe disease)
Elevated creatinine, BUN (renal involvement — characteristically with hypokalemia)
Elevated bilirubin and transaminases (hepatic involvement; AST/ALT typically <200 U/L, bilirubin often disproportionately high)
Elevated CK (rhabdomyolysis)
CSF: lymphocytic pleocytosis with normal glucose (aseptic meningitis pattern)
Available treatment methods
Treatment and Management
Antibiotic treatment is recommended for all confirmed or suspected leptospirosis cases, ideally initiated early in the disease course. Supportive care is critical for severe disease.
Mild Disease (Anicteric Leptospirosis):
Doxycycline 100 mg PO twice daily for 7 days — first-line oral therapy
Azithromycin 500 mg PO daily for 3 days — alternative (pregnancy-safe option)
Amoxicillin 500 mg PO three times daily for 7 days — alternative
Supportive care: hydration, antipyretics (paracetamol), rest
Avoid NSAIDs due to renal and bleeding risks
Monitor for progression to severe disease, especially during the first week
Severe Disease (Weil Disease, SPHS):
IV Penicillin G 1.5 million units IV every 6 hours — traditional first-line for severe disease
IV Ceftriaxone 1g IV once daily — preferred by many clinicians for convenience and broad coverage; equally effective
IV Cefotaxime 1g IV every 6 hours — alternative
Duration: 7 days (minimum)
Note on Jarisch-Herxheimer Reaction:
Can occur within hours of initiating antibiotic therapy (due to rapid leptospiral lysis)
Presents with fever spike, rigors, hypotension, and tachycardia
Generally self-limiting; manage with supportive care
Does not necessitate stopping antibiotics
Supportive Care for Severe Disease:
Fluid management: Careful IV fluid resuscitation; avoid fluid overload in patients with renal failure and pulmonary hemorrhage
Renal replacement therapy: Hemodialysis or CRRT for severe acute kidney injury (recovery expected in most survivors)
Mechanical ventilation: For SPHS and respiratory failure; lung-protective ventilation strategies
Blood products: Platelet transfusion for severe thrombocytopenia; packed RBCs for hemorrhage
Vasopressors: For refractory hypotension
Cardiac monitoring: For patients with myocarditis or arrhythmias
Chemoprophylaxis:
Doxycycline 200 mg PO once weekly has been used for short-term prophylaxis in high-risk settings (military, adventure races, flood response)
Evidence for efficacy is mixed; a meta-analysis showed ~50% reduction in clinical disease
Not routinely recommended for all travelers but may be considered for specific high-risk exposures
Most cases are effectively treated with early diagnosis.
How to protect yourself
Prevention Strategies
No universally available human vaccine exists for leptospirosis. Prevention focuses on reducing exposure to contaminated water and animals, environmental management, and targeted chemoprophylaxis.
Personal Protective Measures:
Avoid contact with potentially contaminated water: Do not wade, swim, or kayak in freshwater bodies (ponds, rivers, flooded areas) in endemic regions, especially after heavy rain
Cover cuts and abrasions: Use waterproof dressings on all skin wounds before potential exposure
Wear protective footwear: Boots (preferably rubber) when walking through wet areas, farmland, or floodwaters
Wear gloves and protective clothing when handling animals, animal tissues, or cleaning animal housing
Practice good hygiene: Wash hands thoroughly after animal contact; shower after freshwater exposure in endemic areas
Do not drink untreated freshwater from potentially contaminated sources
Occupational Prevention:
Rodent control in workplaces (farms, warehouses, sewers, markets)
PPE for high-risk workers: Waterproof boots, gloves, goggles, and face shields for sewage workers, farmers, and abattoir workers
Veterinary measures: Livestock vaccination (where available), drainage of waterlogged fields, livestock housing hygiene
Environmental and Community Measures:
Rodent control programs: Reduce the primary reservoir in urban and periurban areas
Flood preparedness: Rapid drainage, public advisories against contact with floodwater
Sanitation: Proper waste disposal and sewage management
Education: Community awareness campaigns in endemic areas, particularly before rainy seasons
Vaccination:
Human vaccines exist but have limited availability: Inactivated whole-cell vaccines are licensed in some countries (Cuba, China, France, Japan)
These vaccines are serovar-specific and do not provide cross-protection against all serovars
Duration of immunity is limited (requires annual boosters)
Not widely recommended for travelers
Newer subunit and conjugate vaccines are in development
Chemoprophylaxis:
Doxycycline 200 mg PO once weekly — used for short-term prophylaxis during high-risk exposure
Evidence: One RCT (Takafuji 1984) showed 95% reduction in military setting; subsequent meta-analysis (Brett-Major 2009) showed ~50% overall efficacy — results vary by setting
Recommended by some experts for: military deployments, flood response workers, adventure sports participants in highly endemic areas
Duration: start before exposure, continue through exposure period and 1 week after
Not routinely recommended for all travelers
Preparation is the best protection.
Travel Advice
Leptospirosis is an increasingly recognized cause of febrile illness in travelers returning from tropical destinations, particularly those involved in freshwater activities.
High-Risk Destinations:
Southeast Asia: Thailand, Philippines, Indonesia, Malaysia, Vietnam, Laos, Cambodia — leading destinations for travel-associated leptospirosis
South Asia: India (particularly during monsoon season), Sri Lanka, Bangladesh, Nepal
Central and South America: Brazil, Peru, Costa Rica, Nicaragua, Haiti, Colombia
Pacific Islands: Hawaii, Fiji, Samoa, Palau
Africa: Sub-Saharan tropical countries, particularly during floods
Caribbean: Trinidad, Jamaica, Barbados
High-Risk Activities:
White-water rafting, kayaking, canoeing
Canyoning, caving (spelunking)
Freshwater swimming (rivers, lakes, waterfalls) in endemic areas
Jungle trekking through wet terrain
Eco-challenge and adventure races (historically linked to outbreaks)
Rice paddy agriculture or farm visits
Volunteer work in flood-affected or slum areas
Pre-Travel Recommendations:
During Travel:
Minimize contact with freshwater in endemic areas, especially after rain
Cover all wounds with waterproof dressings before freshwater exposure
Wear protective footwear in wet environments
Shower promptly after freshwater exposure
Avoid swallowing freshwater while swimming or during water sports
Post-Travel:
Seek medical attention if fever, severe headache, myalgia (especially calf pain), or jaundice develops within 2-30 days of return
Inform clinicians of specific water and animal exposures during travel
Mention leptospirosis specifically, as it is frequently not considered in the initial differential
Early antibiotic treatment significantly improves outcomes
Statistics and geographic data
Epidemiology
Leptospirosis is the most widespread zoonotic disease globally, with a disproportionately high burden in tropical low-income settings.
Global Burden:
Estimated 1.03 million cases and 58,900 deaths annually (Global Burden of Disease, 2015)
Highest incidence in tropical and subtropical regions, particularly in South and Southeast Asia, Central and South America, and Oceania
Significantly underreported due to nonspecific symptoms, lack of diagnostic capacity, and low clinical awareness
DALYs lost estimated at 2.9 million annually — comparable to or exceeding many higher-profile NTDs
Incidence Rates:
Tropical regions: 10-100+ per 100,000/year (higher during outbreaks)
Temperate regions: 0.1-1 per 100,000/year
Urban slums in tropical cities during floods: attack rates can reach 100-500 per 100,000
Outbreak-associated incidence may far exceed baseline
Notable Outbreaks:
Philippines (annually): 500-3,000 reported cases per year; major floods (e.g., Typhoon Ondoy 2009) cause large epidemics
Brazil: Major urban outbreaks in Sao Paulo, Rio de Janeiro, and Salvador during rainy seasons; >3,000 cases reported annually
India: Monsoon-associated outbreaks in Mumbai, Kerala, Gujarat; estimated >5,000 cases/year
Sri Lanka: Endemic with seasonal peaks; 5,000-7,000 cases/year
International sporting events: Springfield, Illinois Triathlon (1998), Eco-Challenge Borneo (2000), Dusi Canoe Marathon South Africa (multiple years)
Transmission Ecology:
Leptospira excreted in urine of reservoir animals (rats, dogs, cattle, pigs)
Organisms survive for weeks in warm (>20°C), moist, neutral-alkaline environments
Humans are incidental hosts; human-to-human transmission is extremely rare
Seasonal peaks coincide with rainy seasons and monsoons
Climate change (increased flooding frequency and intensity) is expected to increase global burden
Demographic Distribution:
Male-to-female ratio: 3-4:1 (largely occupational bias)
Highest incidence in working-age adults (20-49 years)
Children in endemic areas are also at significant risk (waterplay, bare feet)
Increasingly recognized in urban populations (not just rural/agricultural)
Who is most at risk
Risk Factors
Risk factors for leptospirosis relate to exposure to contaminated water or animals, and host factors that influence disease severity.
Environmental and Exposure Risk Factors:
Flooding: The single most important risk factor globally. Urban flooding in tropical cities drives epidemic leptospirosis (e.g., Mumbai floods, Manila floods, Brazilian urban outbreaks).
Freshwater exposure: Swimming, wading, rafting in potentially contaminated rivers, lakes, and streams
Occupational exposure:
Urban slum residence: Poor sanitation, proximity to rats, flooding
Animal contact: Rats (primary reservoir), dogs, cattle, pigs, horses
Recreational exposure: Adventure sports, triathlon, eco-challenge events in endemic areas
Rainy/monsoon season: Highest incidence during and after heavy rains
Risk Factors for Severe Disease (Weil Disease/SPHS):
Delay in antibiotic treatment — the most modifiable risk factor
Age >40 years — associated with higher mortality
Male sex — higher incidence (occupational bias) and possibly more severe disease
High initial leptospiral burden — related to intensity and duration of exposure
Certain serovars: L. interrogans serovar Icterohaemorrhagiae and Copenhageni are associated with more severe disease
Pre-existing liver disease (alcohol-related hepatitis, chronic hepatitis B/C)
Chronic kidney disease
Immunosuppression
Thrombocytopenia at presentation — predictor of severe outcome
Protective Factors:
Use of protective clothing and footwear in wet environments
Rodent control in and around dwellings
Prompt antibiotic treatment upon symptom onset
Previous infection provides serovar-specific immunity (but not cross-serovar)
Avoidance of freshwater exposure in endemic areas during flooding events
Potential complications
Complications
Leptospirosis complications arise from immune-mediated organ damage and direct leptospiral toxicity, primarily affecting the kidneys, liver, lungs, and eyes.
Renal Complications:
Acute kidney injury (AKI): The hallmark of severe leptospirosis. Occurs in 40-60% of Weil disease cases. Characteristically non-oliguric and hypokalemic (distinguishing it from most other causes of AKI). Mechanism involves interstitial nephritis and proximal tubular dysfunction. Most patients who survive recover renal function, though dialysis may be required during the acute phase.
Chronic kidney disease: Uncommon but may follow severe AKI, particularly with delayed treatment or recurrent episodes.
Hepatic Complications:
Icteric hepatitis: Cholestatic jaundice with elevated conjugated bilirubin (often >15 mg/dL). Unlike viral hepatitis, transaminases are usually only mildly elevated (<200 U/L) — a useful differentiating feature. Hepatocellular necrosis is generally mild; liver failure is uncommon.
Hepatorenal syndrome: Combined liver and kidney failure carries a worse prognosis.
Pulmonary Complications:
Severe pulmonary hemorrhage syndrome (SPHS): The most feared complication. Diffuse alveolar hemorrhage with hemoptysis, respiratory failure, and bilateral pulmonary infiltrates. CFR >50%. Incidence is increasing in recent decades. May occur without jaundice, making diagnosis difficult.
ARDS: Acute respiratory distress syndrome may develop with or without alveolar hemorrhage.
Cardiac Complications:
Myocarditis: Presents with chest pain, arrhythmias (atrial fibrillation, ventricular tachycardia), and heart failure
Conduction abnormalities: PR prolongation, bundle branch block, ST-T changes
Hemodynamic instability: Myocardial depression contributing to shock
Ocular Complications:
Leptospiral uveitis: May develop 2 weeks to 2 years after acute infection. Presents with eye pain, photophobia, blurred vision. Can be bilateral and recurrent. Responds to topical corticosteroids.
Endophthalmitis: Rare but severe
Hemorrhagic Complications:
DIC: With consumption of clotting factors and platelets
Gastrointestinal hemorrhage: Hematemesis, melena
Subarachnoid hemorrhage: Rare but reported
Other Complications:
Rhabdomyolysis: Elevated CK, myoglobinuria contributing to AKI
Pancreatitis: Uncommon but documented
Guillain-Barre syndrome: Rare post-infectious complication
Persistent fatigue and post-leptospirosis syndrome: Prolonged malaise, headaches, and depression lasting months
Expected outcomes and recovery
Prognosis and Outcomes
Prognosis varies enormously across the clinical spectrum of leptospirosis, from full recovery in mild cases to high mortality in severe pulmonary and hepatorenal disease.
Mild/Anicteric Leptospirosis:
Excellent prognosis with full recovery expected
Self-limiting in most cases, even without antibiotic treatment
Duration: 1-3 weeks
Antibiotic treatment shortens illness duration and reduces complications
Residual fatigue and myalgia may persist for weeks
Weil Disease (Icteric Leptospirosis):
Case fatality rate: 5-15% with appropriate treatment
CFR rises to 20-40% in settings with limited ICU resources
Acute kidney injury is usually reversible — most survivors recover renal function fully within weeks
Jaundice resolves over 2-4 weeks after clinical improvement
Key prognostic factors: age, delay to treatment, degree of renal impairment, thrombocytopenia
Severe Pulmonary Hemorrhage Syndrome:
CFR exceeds 50%, even with ICU care
Rapid onset and progression — death may occur within 72 hours of respiratory symptom onset
Early intubation and mechanical ventilation may improve outcomes
Survivors generally recover pulmonary function
Predictors of Poor Outcome:
Altered mental status or coma at presentation
Oliguria or anuria
Pulmonary hemorrhage or ARDS
Serum creatinine >3 mg/dL
Serum bilirubin >10 mg/dL
Thrombocytopenia (<70,000/uL)
Age >40 years
Delay in antibiotic initiation >4 days from symptom onset
Long-Term Sequelae:
Chronic uveitis: May develop weeks to months after acute infection; responds to topical steroids
Chronic kidney disease: Uncommon but reported after severe AKI
Chronic fatigue and depression: Reported in a subset of survivors
Recurrent headaches and myalgia: May persist for months
Immunity to the infecting serovar develops but does not protect against other serovars (reinfection with different serovars is possible)
The content on this page is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. If you have health concerns, consult a qualified healthcare professional. Medova is not a medical service provider.
Full terms of useKnow which vaccine you need? Great. Not sure? Just tell us your destination — we will figure it out and match you with a clinic. Free, no obligation.